{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:38:06Z","timestamp":1792442286649,"version":"4.5.0"},"reference-count":40,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["TF-2020-17"],"award-info":[{"award-number":["TF-2020-17"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1170958"],"award-info":[{"award-number":["1170958"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,4,4]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Bronchiectasis is being diagnosed increasingly in children and adolescents. Recurrent respiratory exacerbations are common in children and adolescents with this chronic pulmonary disorder. Respiratory exacerbations are associated with an impaired quality of life, poorer long-term clinical outcomes, and substantial costs to the family and health systems. The 2021 European Respiratory Society (ERS) clinical practice guideline for the management of children and adolescents with bronchiectasis provided a definition of acute respiratory exacerbations for clinical use but to date there is no comparable universal definition for clinical research. Given the importance of exacerbations in the field, this ERS Task Force sought to obtain robust definitions of respiratory exacerbations for clinical research. The panel was a multidisciplinary team of specialists in paediatric and adult respiratory medicine, infectious disease, physiotherapy, primary care, nursing, radiology, methodology, patient advocacy, and parents of children and adolescents with bronchiectasis. We used a standardised process that included a systematic literature review, parent survey, and a Delphi approach involving 299 physicians (54 countries) caring for children and adolescents with bronchiectasis. Consensus was obtained for all four statements drafted by the panel as the disagreement rate was very low (range 3.6\u20137.2%). The panel unanimously endorsed the four consensus definitions for 1a) non-severe exacerbation and 1b) severe exacerbation as an outcome measure, 2) non-severe exacerbation for studies initiating treatment, and 3) resolution of a non-severe exacerbation for clinical trials involving children and adolescents with bronchiectasis. This ERS Task Force proposes using these internationally derived, consensus-based definitions of respiratory exacerbations for future clinical paediatric bronchiectasis research.<\/jats:p>","DOI":"10.1183\/13993003.00300-2022","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T20:45:25Z","timestamp":1655844325000},"page":"2200300","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials"],"prefix":"10.1183","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-3706","authenticated-orcid":false,"given":"Anne B.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-2138","authenticated-orcid":false,"given":"Angela","family":"Zacharasiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7533-2315","authenticated-orcid":false,"given":"Vikas","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-4127","authenticated-orcid":false,"given":"Efthymia","family":"Alexopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Claydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6596-1596","authenticated-orcid":false,"given":"Carolina","family":"Constant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fortescue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-4612","authenticated-orcid":false,"given":"Ahmad","family":"Kantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"other members of Child-BEAR-Net","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Collaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Douros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Griese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Mazulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Midulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Proesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Yerkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"2026061109101083000_60.5.2200300.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31554-X"},{"key":"2026061109101083000_60.5.2200300.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02990-2020"},{"key":"2026061109101083000_60.5.2200300.3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fped.2017.00084","article-title":"Review: quality of life in children with noncystic fibrosis bronchiectasis","volume":"5","author":"Nathan","year":"2017","journal-title":"Front Pediatr"},{"key":"2026061109101083000_60.5.2200300.4","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00122-2021"},{"key":"2026061109101083000_60.5.2200300.5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","article-title":"Bronchiectasis","volume":"4","author":"Chalmers","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2026061109101083000_60.5.2200300.6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/resp.13828","article-title":"Cost of hospitalisation for bronchiectasis exacerbations in children","volume":"25","author":"Goyal","year":"2020","journal-title":"Respirology"},{"key":"2026061109101083000_60.5.2200300.7","unstructured":"Gibson GJ , Loddenkemper R , Sibille Y , et al. , eds. Bronchiectasis. In: European Lung White Book. Sheffield, European Respiratory Society, 2013; pp. 176\u2013183."},{"key":"2026061109101083000_60.5.2200300.8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/resp.13888","article-title":"Counting the cost of bronchiectasis","volume":"25","author":"Gao","year":"2020","journal-title":"Respirology"},{"key":"2026061109101083000_60.5.2200300.9","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ppul.24491","article-title":"Children with bronchiectasis have poorer lung function than those with cystic fibrosis and do not receive the same standard of care","volume":"54","author":"Prentice","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2026061109101083000_60.5.2200300.10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/resp.13291","article-title":"\u2018Good enough\u2019 is \u2018not enough\u2019 when managing indigenous adults with bronchiectasis in Australia and New Zealand","volume":"23","author":"McCallum","year":"2018","journal-title":"Respirology"},{"key":"2026061109101083000_60.5.2200300.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0679"},{"key":"2026061109101083000_60.5.2200300.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2932"},{"key":"2026061109101083000_60.5.2200300.13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12913-019-4414-5","article-title":"Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study","volume":"19","author":"Lovie-Toon","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"2026061109101083000_60.5.2200300.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017"},{"key":"2026061109101083000_60.5.2200300.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.05.007"},{"key":"2026061109101083000_60.5.2200300.16","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21518"},{"key":"2026061109101083000_60.5.2200300.17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011439.pub2."},{"key":"2026061109101083000_60.5.2200300.18","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/jama.2012.5214","article-title":"Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial","volume":"307","author":"Rosenfeld","year":"2012","journal-title":"JAMA"},{"key":"2026061109101083000_60.5.2200300.19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026061109101083000_60.5.2200300.20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S2213-2600(19)30254-1","article-title":"Efficacy of oral amoxicillin\u2013clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial","volume":"7","author":"Goyal","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026061109101083000_60.5.2200300.21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","article-title":"Amoxicillin\u2013clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multi-centre, double-blind, non-inferiority randomised controlled trial","volume":"392","author":"Goyal","year":"2018","journal-title":"Lancet"},{"key":"2026061109101083000_60.5.2200300.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2003.tb00416.x"},{"key":"2026061109101083000_60.5.2200300.23","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21550"},{"key":"2026061109101083000_60.5.2200300.24","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201312-456OC"},{"key":"2026061109101083000_60.5.2200300.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104236"},{"key":"2026061109101083000_60.5.2200300.26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ppul.23380","article-title":"Pediatric bronchiectasis: no longer an orphan disease","volume":"51","author":"Goyal","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2026061109101083000_60.5.2200300.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01657-2021"},{"key":"2026061109101083000_60.5.2200300.28","unstructured":"Australian National Health and Medical Research Council Centre for Research Excellence in Paediatric Bronchiectasis . AusBREATHE: Australian Bronchiectasis Centre of Research Excellence esp. for Aboriginal and Torres Strait Islander Children. 2021. www.crelungs.org.au Date last accessed: 16 March 2021."},{"key":"2026061109101083000_60.5.2200300.29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ppul.25206","article-title":"Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: a randomized control trial","volume":"56","author":"Anuradha","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026061109101083000_60.5.2200300.30","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136119"},{"key":"2026061109101083000_60.5.2200300.31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5152\/TurkThoracJ.2018.17081","article-title":"Evaluation of noncystic fibrosis bronchiectasis using clinical and radiological scorings in children","volume":"19","author":"Basaran","year":"2018","journal-title":"Turk Thorac J"},{"key":"2026061109101083000_60.5.2200300.32","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305147"},{"key":"2026061109101083000_60.5.2200300.33","doi-asserted-by":"publisher","DOI":"10.1159\/000085362"},{"key":"2026061109101083000_60.5.2200300.34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2213-2600(20)30058-8","article-title":"Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"8","author":"Kobbernagel","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026061109101083000_60.5.2200300.35","first-page":"44","article-title":"Lack of efficacy of an immunomodulatory macrolide in childhood HIV related bronchiectasis: a randomised, placebo-controlled trial","volume":"5","author":"Masekela","year":"2013","journal-title":"J Antivir Antiretrovir"},{"key":"2026061109101083000_60.5.2200300.36","first-page":"2768","article-title":"The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: a multi-centre, double-blind, randomised controlled trial","volume":"14","author":"O'Grady","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2026061109101083000_60.5.2200300.37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1378\/chest.14-0126","article-title":"Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease\/bronchiectasis","volume":"146","author":"Redding","year":"2014","journal-title":"Chest"},{"key":"2026061109101083000_60.5.2200300.38","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/ppul.23479","article-title":"Recovery of baseline lung function after pulmonary exacerbation in children with primary ciliary dyskinesia","volume":"51","author":"Sunther","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2026061109101083000_60.5.2200300.39","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00147-2018"},{"key":"2026061109101083000_60.5.2200300.40","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23304"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00300-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:10:21Z","timestamp":1781194221000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00300-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,11,3]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1183\/13993003.00300-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00300-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]}}}